What is it? Why is it important?

A Statistical Analysis Plan (SAP) is an independent document (i.e. separate from the study protocol) written by the study statistician. The aim is to provide a more in depth supplement to the existing statistical section of the study protocol, where the statistical analysis plan is described in less detail.

 

The SAP provides a statistical roadmap for statisticians and researchers, outlining a detailed description of the (statistical) methods used to analyse the study outcome(s)/endpoint(s). It provides assurance that data analysis is conducted in a transparent, rigorous, and pre-defined manner.

 

Deviations from an approved SAP (e.g., modification of the analysis method or the analysis of additional outcomes not defined in the study protocol) must be clearly documented and justified. Some changes require a protocol amendment that must be approved by the Ethics Committee (EC) and, as applicable Swissmedic (e.g. introduction of additional Interim Analysis (AI) or the omission of a planned IA)

What do I need to do?

As a SP-INV:

  • Discuss with a statistician the necessity (or not) of having an SAP for your study. An SAP is usually required for high-risk studies using complex study designs and statistical methods, including the requirement of  IA(s)
  • Once the protocol is finalised, ask a study statistician to write a SAP prior to any data analysis
  • Date and sign the SAP together with the statistician. Once approved, the SAP becomes an official document that must be complied with during data analysis, and the implementation of IAs

Where can I get help?

Your local CTU can support you with experienced staff regarding this topic

References

ICH Topic E9 – see in particular

  • 4.1 Trial monitoring and interim analysis
  • 5.1 Prespecification of the analysis
Abbreviations
  • CTU – Clinical Trials Unit
  • ICH – International Council for Harmonisation
  • SAP - Statistical Analysis Plan
  • SP-INV – Sponsor Investigator
Development ↦ Statistic Methodology ↦ Analysis Plan ↦ Procedures
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Development ↦ Statistic Methodology ↦ Analysis Plan ↦ Procedures

Please note: the Easy-GCS tool is currently under construction.